Type 2 diabetes mellitus is on the increase worldwide. Current treatments possess undesirable side-effects and therefore investigations into alternative remedies, which may be cost-effective and devoid of such side-effects, are on-going. Aqueous and methanol extracts of the bark of Sclerocarya birrea (A. Rich.) Hochst. subsp. caffra (Sond.) Kokwaro (Anacardiaceae) and Ziziphus mucronata Willd. subsp. mucronata (Rhamnaceae) were subjected to testing in order to assess their in vitro anti-diabetic activity. Total polyphenolic content and antioxidant activity, as well as the effect on α-amylase, α-glucosidase and cytotoxicity, were measured. Furthermore, glucose uptake was evaluated in C2C12 myotubes, 3T3-L1 adipocytes and HepG2 hepatocarcinoma cells, and insulin secretion in RIN-m5F rat pancreatic β-cells. The extracts of both plants inhibited the activities of α-amylase and α-glucosidase in a concentration dependent manner, with results being comparable with the positive control, acarbose. All the extracts contained antioxidant activity, with the methanol extracts of S. birrea displaying the strongest free radical scavenging capacity (IC 50 = 2.16 µg/mL). Most of the extracts were not cytotoxic to the cell lines with IC 50 values > 100 µg/mL. Extracts of both plants significantly increased glucose uptake in C2C12, 3T3-L1 and HepG2 cells. However, insulin secretion from RIN-m5F cells was not altered. This study provides evidence that the plants possess in vitro anti-diabetic properties.
In 2011, about 366 million people were diagnosed with diabetes mellitus and this number is projected to increase to 552 million by 2030 [1] . Type 2 diabetes mellitus (T2DM) has rapidly become the most prevalent chronic disease worldwide and remains one of the major health challenges of the 21 st century [2] . It is characterized by impaired insulin secretion and/or efficacy that give rise to chronic hyperglycemia [2] .
Oxidative stress is greatly increased under conditions of sustained hyperglycaemia [3] . Increased free radical generation, which arises from increased glycation, glucose auto-oxidation and alterations in polyol pathway activity, exerts a modular effect on the level of oxidative stress [3] . These free radicals, that may also originate from macrophages, T-cells and natural killer cells, are believed to cause damage to β-cells [4] . It is for this reason that antioxidants may prove effective in reducing elevated serum glucose levels in T2DM and could thus alleviate its symptoms and associated secondary complications [6] . Therefore, antioxidant therapies specifically targeting the mechanisms of diabetes-induced oxidative stress might be worth considering as part of the therapeutic strategy to prevent downstream diabetic complications [3] .
Insulin is secreted in response to high blood sugar levels. It serves to suppress glucose output from the liver and stimulates glucose uptake and metabolism in skeletal muscle and adipose tissue. As T2DM progresses, β-cells start to deteriorate in function and fail to sustain normal insulin levels, resulting in the necessity of insulin replacement therapy [6, 7] . The ideal anti-diabetic drug should alleviate hyperglycemia and improve pancreatic β-cell function, whilst not causing hypoglycemia [8] .
Two enzymes that play a key role in diabetes are α-amylase and α-glucosidase. α-Amylase catalyzes the hydrolysis of starch to a mixture of smaller oligosaccharides consisting of maltose, maltotriose and oligoglucans [9] . These products are further degraded to glucose by α-glucosidase, after which they are absorbed into the bloodstream [9] . Increased activity of α-amylase and α-glucosidase causes post-prandial hyperglycemia, which can cause damage to β-cells, resulting in impaired insulin secretion and reduced glucose uptake [10] . Inhibition of these enzymes delays digestion of carbohydrates and prolongs overall carbohydrate digestion time, which results in a reduction in the rate of glucose absorption and post-prandial blood glucose levels [11] . Hence, retardation of carbohydrate digestion through inhibition of αamylase and/or α-glucosidase, is a major target for the management of T2DM.
Herbal remedies are widely used for the treatment of T2DM. Two such plants include Sclerocarya birrea (A. Rich.) Hochst. subsp. caffra (Sond.) Kokwaro (Anacardiaceae) and Ziziphus mucronata Willd. subsp. mucronata (Rhamnaceae). Despite a long history of traditional use for the treatment of diabetes [12, 13] , the effects of these plants on anti-diabetic parameters, are still not fully described. The aim of the present study was to investigate the in vitro antidiabetic effects of the aqueous and methanol extracts of the bark of both plants on α-amylase and α-glucosidase, as well as glucose uptake and insulin secretion.
Aqueous and methanol extracts of S. birrea produced 9.1% and 15.0% extraction yields, respectively. The extraction yields for aqueous and methanol extracts of Z. mucronata were 4.7% and 10.2%, respectively. Methanol extracts of S. birrea were found to contain approximately 10-fold more flavonoid and phenolic compounds than the corresponding aqueous extracts (Table 1) . A similar, more substantial trend was observed with Z. mucronata.
Oxidative stress plays a major role in the pathogenesis of T2DM and is greatly increased during hyperglycemia [3] . The extracts scavenged both the ABTS •+ and DPPH radicals in a concentrationdependent manner. The methanol extract of S. birrea displayed the lowest IC 50 value (2.2 µg/mL), which implies that it has the strongest radical scavenging activity ( Table 1 ). The antioxidant activity of the latter extract was more potent than Trolox in both assays. This strong antioxidant activity of S. birrea is supported by other authors [14, 15] . Adewusi and Steenkamp [16] found the extract of Z. mucronata to scavenge the ABTS •+ radical with the same intensity as that reported in the present study.
The main goal of treatment in the early management of T2DM is to control plasma glucose levels and reduce post-prandial hyperglycemia, which are crucial for reduction of microvascular and macrovascular complications [9] . This is achieved by inhibiting the key enzymes in carbohydrate digestion, α-amylase and α-glucosidase [9] . These enzymes are recognized as potential drug targets for the modulation of postprandial hyperglycemia [9] . Acarbose is an example of an α-glucosidase inhibitor currently in clinical use, but its prices are high and clinical side effects such as abdominal distention, flatulence, meteorism and diarrhea are common [17] .
The aqueous (all three concentrations) and methanol (62 µg/mL) extracts of S. birrea demonstrated α-amylase inhibitory activity comparable with that of the positive control, acarbose ( Figure 1) . The latter is supported by Mogale et al. [18] . Only the methanol extracts of Z. mucronata demonstrated α-amylase inhibition. The aqueous and methanol extracts of both plants inhibited α-glucosidase activity, in a concentration-dependent manner ( Figure 1 ). The mechanism by which the crude extracts of both plants exert their inhibitory effects could be attributed to the presence of a high content of polyphenols, predominantly flavonoids. Plant polyphenols have been shown to inhibit both αamylase and α-glucosidase activities [19] .
S. birrea showed no inherent cytotoxicity in all four cell lines tested, with IC 50 values > 100 µg/mL. The low degree of toxicity observed in the present study is supported by the findings of van de Venter et al. [8] and McGaw et al. [20] . However, contrary findings have been reported, where cytotoxicity has been noted for this plant [12] .
This is the first study, to our knowledge, to determine the cytotoxicity of the crude bark extracts of Z. mucronata in the cell lines tested; 3T3-L1, C2C12, HepG2 and RIN-m5F. Although Z. mucronata mainly possessed low toxicity (IC 50 > 100 µg/mL), the methanol extracts were cytotoxic to HepG2 and RIN-m5F cell lines with IC 50 values of 85.3 μg/mL and 65.8 μg/mL, respectively. The results from the present study could point to some selective toxicity to hepatocytes and β-cells, but this needs to be confirmed. Similar findings of low toxicity (> 100 µg/mL) are supported by other in vitro studies, where the SH-SY5Y neuroblastoma cell line and the brine shrimp lethality tests were used [20, 21] . Methanol extracts of the roots of Z. mucronata (100 µg/mL) have been reported to decrease cell viability by  25% in HeLa (cervival carcinoma), HT29 (colon adenocarcinoma) and A431 (skin carcinoma) cells [22] .
A hormetic effect was observed in most survival curves, except for those of C2C12 cells treated with the methanol extract of S. birrea and the aqueous extract of Z. mucronata. Exposing C2C12 cells to low concentrations (1.56-3.13 µg/mL) of S. birrea and Z. mucronata resulted in cell viabilities of less than 100%. This could be attributed to the C2C12 cell line being a fast growing cell line, with a doubling time of only 12 h [23] , which may explain why this effect was only observed in this specific cell line. It is possible that low-dose exposure to the plant extracts inhibited cellular proliferation rather than causing cell death. This decrease in proliferation rate would manifest as a slight decrease in cell viability, compared with the negative controls, in which cell proliferation continued uninhibited.
Various glucose uptake assays exist, which employ different methodologies. In the present study, glucose uptake was monitored in C2C12, HepG2 and 3T3-L1 cells using 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG), a fluorescent analogue of 2-deoxyglucose [24] . 2-NBDG has been shown to provide a good optical marker of glucose metabolism [25] . An increase in fluorescence intensity corresponds to an enhanced uptake of 2-NBDG into the cells, which indicates that a compound possesses insulin-mimetic properties. Insulin secretion was assessed in the RIN-m5F cell line as the cell line provides a good model to assess the ability of glucose-containing crude extracts to stimulate insulin secretion because the cell line is unresponsive to glucose, unlike other pancreatic β-cell lines [26] . Results suggest that crude extracts of S. birrea may possess a greater capacity to promote glucose uptake, rather than promoting insulin secretion ( Figure 2 ). Aqueous and dichloromethane/methanol extracts of the bark, stem and roots of S. birrea were found to enhance glucose utilization in Chang liver, C2C12 and 3T3-L1 cells (12 and 50 µg/mL) [7] , findings which correspond to those of the present study. The glucose-lowering effects of S. birrea, using in vivo models, are known [27] [28] [29] .
Research shows that diabetic rats treated with ethanol stem-bark extracts (60, 120 and 240 mg/kg) have a reduction in blood glucose levels, without significantly affecting pancreatic insulin secretion [12] . This is in agreement with results from the present study where extracts from S. birrea enhanced glucose uptake, but did not significantly stimulate insulin secretion.
The crude extracts of Z. mucronata were more effective than insulin at promoting glucose uptake in C2C12 and 3T3-L1 cells ( Figure 2 ), but failed to produce any significant increase in insulin secretion in the RIN-m5F cells. To the best of the authors' knowledge, no literature regarding the in vitro anti-diabetic effects of crude extracts of Z. mucronata was available at the time of preparation of this manuscript. In vivo studies correspond to the in vitro results obtained in the present study in that hyperglycemia was decreased following treatment with extracts of Ziziphus jujuba [30, 31] .
The findings of the present study suggest that the crude extracts of both plants may possess potent hypoglycemic effects. However, the crude extracts had no significant effect on insulin secretion from RIN-m5F cells. Possible reasons for this observation include: too low test concentrations of the crude extracts used in the experiments and passage number of the cells, both of which have been shown to decrease insulin secretion in RIN-m5F cells [32] .
More than 100 cyclopeptide alkaloids have been isolated from the genus Ziziphus, and the family Rhamnaceae is known to be a rich source of these compounds [13] . These alkaloids have been shown to possess hypoglycemic effects [13] , implicating that they may be responsible for the anti-diabetic activity noted for Z. mucronata.
Various mechanisms have been proposed on how S. birrea may exert its hypoglycemic effects. Some authors have proposed that those of S. birrea appear to be mediated via a mechanism that is similar to that of chlorpropamide, a sulfonylurea anti-diabetic drug, or is related to insulin secretion from pancreatic β-cells [27, 28] . Others postulate that the hypoglycemic effects of S. birrea may be associated with reno-protective and hypotensive effects, and via mechanisms attributed to metformin [12] . An extra-pancreatic mechanism of action for the hypoglycemic effects of S. birrea has also been proposed based on in vitro findings [7] .
The findings of the present study suggest an extra-pancreatic mechanism of action for the hypoglycemic effects of crude extracts of S. birrea and Z. mucronata, possibly acting as insulin-mimetic agents. Additional extra-pancreatic mechanisms that may contribute to their hypoglycemic properties include inhibition of α-amylase and α-glucosidase, and interaction with the insulin receptor.
Interactions with the insulin receptor are known to lead to the activation of biochemical cascades (PI3K and MAPK), which result in GLUT-4 translocation and GLUT-1 synthesis [33] . These plants also contain polyphenols, which have been shown to inhibit α-amylase and α-glucosidase activities, possess anti-hyperglycemic effects and inhibit the development of diabetes mellitus [34, 35] . Furthermore, crude extracts displayed strong antioxidant activity, implying that they could alleviate oxidative stress, improve insulin sensitivity and thus prevent β-cell and microvascular damage associated with T2DM. Findings from this study provide in vitro evidence for the anti-hyperglycemic effects of S. birrea and Z. mucronata. Where, c = concentration obtained from the calibration curve (mg/mL); v = volume obtained from initial extraction of plant material (mL); df = dilution factor of sample; and m = total weight of extract (g).
Experimental

Total flavonoid content (TFC):
TFC was determined using the aluminium trichloride assay method of Dewanto et al. [37] with minor modifications. Where, c = concentration obtained from the calibration curve (mg/mL); v = volume obtained from initial extraction of plant material (mL); df = dilution factor of sample; and m = total weight of extract (g).
ABTS •+ radical scavenging activity:
The ability of the crude extracts to scavenge the 2,2'-azo-bis(3-ethylbenzthiazoline-6sulfonic acid) (ABTS •+ ) free radical was determined following the methods of Awika et al. [38] and Erel [39] , with slight modifications. The ABTS •+ free radical was freshly generated by addition of 3 mM potassium peroxodisulfate solution to 8 mM ABTS •+ . The mixture was left to react in the dark for 12 h at room temperature. The working solution was prepared by diluting ABTS •+ stock solution with phosphate buffer (0.2 M, pH 7.4). A preliminary run was carried out with the crude extracts (half serial dilutions from 1 mg/mL), to give an indication between which concentrations the IC 50 value would lie. From there, a concentration range was selected for further experimentation. The following were added into a 96-well microplate: 15 μL of the extract (final concentration 0.1-100 µg/mL) and 200 μL of ABTS •+ solution.
Trolox was used as positive control. Plates were incubated for 15 min in the absence of light. Absorbance was measured at 630 nm (ELX800 Universal Microplate Reader, Bio-Tek Instruments, Inc.). The extract concentration producing 50% inhibition was calculated from a fitted Hill equation using Graphpad Prism 5.0.
DPPH radical scavenging activity:
The ability of the crude extracts to scavenge the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical was determined following the method described by Gyamfi et al. [40] , with minor modifications. A preliminary run was carried out with the crude extracts (half serial dilutions from 1 mg/mL) to give an indication between which concentrations the IC 50 value would lie. From there, a concentration range was selected for further experimentation. The following were added into a 96-well microplate: 15 µL of the extract (final concentration 0.1-300 µg/mL) and 185 µL of DPPH (0.24 mM). Trolox was used as positive control. Plates were incubated for 15 min in the absence of light. Absorbance was measured at 570 nm [41] . The extract concentration producing 50% inhibition was calculated from a fitted Hill equation using Graphpad Prism 5.0.
α-Amylase inhibition assay:
The bioassay method was adopted from Conforti et al. [42] , with slight modifications. A 0.5%, w/v, starch solution was prepared by mixing 0.125 g of potato starch in 25 mL of 20 mM sodium phosphate buffer with 6.7 mM sodium chloride (pH 6.9), for 15 min at 65⁰C. The color reagent was prepared by mixing sodium potassium tartrate solution (12 g of sodium potassium tartrate tetrahydrate in 8 mL of 2 M sodium hydroxide) and 96 nM of 3,5-dinitrosalicylic acid solution (0.88 g of 3,5-dinitrosalicylic in 46 mL of distilled water). The following were added into a tube: 50 μL of the extract (final concentration 15.6-62.5 µg/mL) and 50 μL of porcine pancreatic α-amylase (2 U/mL). After incubation of the mixture at 25⁰C for 5 min, 100 µL of starch solution was added. After a further incubation of 3 min, 100 µL of color reagent was added and the mixture was incubated at 85⁰C for 15 min. The final mixture was diluted with 800 µL distilled water and 100 µL was added into a 96-well microplate. Acarbose was used as positive control. The absorbance was measured at 540 nm and the α-amylase inhibitory activity was determined using the following equations: Cell culture: C2C12 myoblasts were cultured and differentiated into myotubes, as described by Su and Zhu [45] . Briefly, cells were grown to near-confluence in DMEM containing 10% fetal calf serum, 1% streptomycin/penicillin and non-essential amino acids. The myoblasts were transferred into differentiation medium consisting of DMEM with 5% horse serum for 4 days. The medium was changed every 24 h. Differentiation was confirmed by using phase contrast microscopy. C2C12 myotube cells were used at day 4 in all the experiments. HepG2 cells were maintained in EMEM supplemented with non-essential amino acids and fortified with 10% FCS and 1% streptomycin/penicillin. The medium was changed every 2-3 days, as required. 3T3-L1 fibroblasts were cultured in DMEM supplemented with non-essential amino acids, 10% FCS and 1% streptomycin/penicillin. Differentiation of 3T3-L1 fibroblasts to adipocytes was achieved according to a Life Science protocol [46] . Briefly, the 3T3-L1 fibroblasts were treated with adipocyte differentiation medium (DMEM, 10% FCS, 1 µM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) and 10 µg/mL insulin) for 3 days. On day 4, the cells were treated with adipocyte maturation medium (DMEM, 10% FCS and 10 µg/mL insulin) for an additional 4 days. Differentiation was confirmed by Anti-diabetic activity of two southern African plants Natural Product Communications Vol. 8 (9) 2013 1283 using phase contrast microscopy. Differentiated 3T3-L1 cells were used at day 8 in all experiments. Rin-m5F cells were maintained in RPMI-1640 supplemented with non-essential amino acids and fortified with 10% FCS and 1% streptomycin/penicillin. The medium was replaced after 2-3 days, as required.
Cytotoxicity: Cell viability was assessed using the sulforhodamine B (SRB) assay according to Vichai and Kirtikara [47] . The various cell lines were treated with different concentrations (final concentration range: 0.78 μg/mL-100 μg/mL) of the crude extracts for 24 h. The SRB assay was started by removing 100 μL of the supernatant from the wells, and addition of 100 μL of 30%, v/v, trichloroacetic acid to the wells, after which the plates were incubated overnight at 4°C. Thereafter, plates were washed 4 times with distilled water, allowed to dry, and 100 μL of SRB (0.057%, w/v) was added to the wells. Following a 30 min incubation period, plates were rinsed twice with 1% acetic acid to remove unbound dye. Thereafter, plates were left to dry and 200 μL tris-base solution (10 mM, pH 10.5) was added to the wells. Plates were incubated for 30 min at room temperature and the absorbance was measured spectrophotometrically at 540 nm (reference 630 nm) using a plate reader. Cell viability was calculated using the equation below:
IC 50 values were calculated by fitting a Hill equation with variable slope using GraphPad Prism 5.
Glucose uptake: The glucose uptake assay was carried out according to Zou et al. [48] , with minor modifications. C2C12, HepG2 and 3T3-L1 cells were used at subconfluence after 24 h incubation and plated into 96-well plates at 1.5 x 105 cells/mL, 2.5 x 105 cells/mL, 1.5 x 105 cells/mL, respectively. Thereafter, the cells were treated with 50 µL of culture medium in the presence of fluorescent 2-NBDG together with 3 sub-toxic concentrations (final concentration 1.56-6.25 µg/mL) of the plant extracts. Insulin was used as a positive control. Medium controls were included to account for any background signal, and wells containing medium and cells served as the negative control. Plates were incubated at 37⁰C with 5% CO 2 for 1 h. The 2-NBDG uptake reaction was stopped by removing the incubation medium and washing the cells once with cold PBS. Cells in each well were resuspended in 100 µL cold PBS and the plates were read at an excitation wavelength of 460 nm and emission wavelength of 544 nm (BMG FluoStar Optima fluorescent plate reader). The glucose uptake activity was evaluated by comparing the fluorescence of the experimental wells with the negative and positive controls.
Insulin secretion:
The insulin secretory assay was carried out according to Nomura et al. [49] . RIN-m5F cells were plated into 96-well plates and used at subconfluence after 24 h incubation. Thereafter, the cells were treated with 100 µL of 3 sub-toxic concentrations (final concentration 1.56-6.25 µg/mL) of the plant extracts and incubated for 3 h. Medium controls were included to account for any background signal and wells containing medium and cells served as the negative control. The plates were centrifuged at 1000 g for 10 min, after which the insulin concentration of each supernatant was determined using an ELISA kit [Insulin (Rat) Ultrasensitve ELISA kits (DRG International, USA)], according to the manufacturer's instructions. Absorbance was measured at 450 nm and the activity was evaluated by comparing the absorbance of the experimental wells with the negative control.
Statistical analysis:
All experiments were carried out in triplicate on 3 separate occasions and results are expressed as mean ± SEM. GraphPad Prism 5 was used for all data manipulation and analyses. Results of the glucose uptake assays are compared with the positive control (insulin) and the negative control, whereas the results of the insulin secretion assays are compared with the negative control, through the use of unpaired t-Tests. Significant differences from the positive control are indicated by , representing p < 0.05, whereas significant differences from the negative control are indicated by , representing p < 0.05.
